ALEXANDRIA Study Egypt

Trial Identifier: D133FR00138
Sponsor: AstraZeneca
NCTID:: NCT03583463
Start Date: October 2018
Primary Completion Date: January 2021
Study Completion Date: January 2021
Condition: Breast Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Egypt Alexandria, Egypt
Egypt Cairo, Egypt
Egypt El Gharbia, Egypt
Egypt El Menofia, Egypt
Egypt Gharbia, Egypt
Egypt Giza, Egypt
Egypt Luxur, Egypt
Egypt Zagazig, Egypt